- 3.5Impact Factor
- 4.4CiteScore
- 26 daysTime to First Decision
Journal History
| 2017 | The inaugural issue was released. Epigenomes was published as a quarterly journal. |
| 2018 | The Epigenetics Society (ES) became affiliated to Epigenomes. Epigenomes was indexed in Emerging Sources Citation Index (ESCI)—Web of Science (Clarivate Analytics), starting with Volume 1 (Issue 1). |
| 2021 | Epigenomes was indexed in Scopus (Elsevier), starting with Volume 1 (Issue 1). Epigenomes was indexed in PubMed—National Library of Medicine (NLM), starting with Volume 3 (Issue 1). Epigenomes was indexed in PubMed Central (PMC)—National Library of Medicine (NLM), starting with Volume 3 (Issue 1). |
| 2022 | Epigenomes received its first CiteScore (2021) of 2.9. |
| 2023 | Epigenomes received its first Impact Factor (2022) of 2.5. Epigenomes received its 2022 CiteScore (3.1). |
| 2024 | Epigenomes received its 2023 Impact Factor (2.5). Epigenomes received its 2023 CiteScore (3.8). |
| 2025 | Epigenomes received its 2024 Impact Factor (3.5). Epigenomes received its 2024 CiteScore (4.4). |
Editor-in-Chief
| 2016–2017 | Editor-in-Chief: Prof. Dr. Stephen B. Baylin Editor-in-Chief: Prof. Dr. Peter A. Jones |
| 2017–2018 | Editor-in-Chief: Prof. Dr. Muller Fabbri |
| 2018–present | Editor-in-Chief: Prof. Dr. Ernesto Guccione |
Epigenomes - ISSN 2075-4655